CURE ADOA FOUNDATION
The road to treatment
We regularly contact various researchers and pharmaceutical companies, nationally and internationally, about the treatment and cure of ADOA(-plus). Below you will find the reports of these conversations and interviews. Thanks to a number of fanatical volunteers led by Peter Makai.

The road to treatment 22
The road to treatment 22 At the end of February we had a consultation with Phosphoenix, a Dutch company that is developing a

The road to treatment 21
Dr. Astrid Plomp was present on the Anniversary Day on November 18, 2023 and spoke about clinical genetics. What does a clinical geneticist do? The first

The road to treatment 20
The road to treatment 20 Fatigue – Ruth van Nispen and Manon Veldman Ruth van Nispen and Manon Veldman were present at the ADOA day

The road to treatment 19
The road to treatment 19 ADOA and ADOA+ On our Anniversary day on November 18 in Doorn, René de Coo of the Nemo Mitochondrial

The road to treatment 18
The Road to Treatment 18 PYC at the Gateway of Human Studies We recently met with PYC, a company working on a

The road to treatment 17
The road to treatment 17 On our 5th anniversary, Guy Lenaers gave us a presentation about the work he and his colleagues

The road to treatment 16
The Road to Treatment 16 In October we had the pleasure of speaking with Neurophth Therapeutics, a Chinese company developing a gene therapy for

The road to treatment 15
The Road to Treatment 15 Professor Marcela Votruba of Cardiff University in the UK, a researcher who has investigated the link between ADOA and

The road to treatment 14
The Road to Treatment 14 Interview with Professor Xian-Jie Yang of the Stein Eye Institute at the University of California, Los Angeles Would you like

The road to treatment 13
The road to treatment 13 On August 28, 2023, we had an online meeting with Professor Jeffrey Goldberg and Dr. Marius Wernig from the University

The road to treatment 12
The road to treatment 12 Report of meeting with Abeona Therapeutics by Peter Makai. Last summer we had a meeting with Abeona Therapeutics, a company

The road to treatment 11
The road to treatment 11 In some patients, ADOA has developed significantly and a large part of the optic nerve cells have already died. This